Back to Search
Start Over
Multiple sclerosis: closing in on an oral treatment.
- Source :
-
Nature [Nature] 2010 Mar 18; Vol. 464 (7287), pp. 360-2. - Publication Year :
- 2010
- Subjects :
- Administration, Oral
Animals
Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal, Humanized
Clinical Trials, Phase III as Topic
Fingolimod Hydrochloride
Humans
Lysophospholipids metabolism
Mitoxantrone therapeutic use
Multiple Sclerosis immunology
Multiple Sclerosis pathology
Natalizumab
Propylene Glycols adverse effects
Propylene Glycols pharmacology
Randomized Controlled Trials as Topic
Sphingosine administration & dosage
Sphingosine adverse effects
Sphingosine metabolism
Sphingosine pharmacology
Sphingosine therapeutic use
Multiple Sclerosis drug therapy
Propylene Glycols administration & dosage
Propylene Glycols therapeutic use
Sphingosine analogs & derivatives
Subjects
Details
- Language :
- English
- ISSN :
- 1476-4687
- Volume :
- 464
- Issue :
- 7287
- Database :
- MEDLINE
- Journal :
- Nature
- Publication Type :
- Periodical
- Accession number :
- 20237554
- Full Text :
- https://doi.org/10.1038/464360a